TUESDAY, June 29, 2021 (HealthDay News) — People with type 2 diabetes face heightened risks for heart attack and stroke, as well as progressive kidney disease. But a new once-a-week injected drug called efpeglenatide could greatly reduce their odds for those outcomes, new research shows. The clinical trial was conductedContinue Reading

TUESDAY, June 29, 2021 (HealthDay News) — Hospitalized patients with diabetes who hadn’t been taking their medication had more severe cases of COVID-19, a new study shows. “Our results highlight the importance of assessing, monitoring and controlling blood glucose [sugar] in hospitalized COVID-19 patients from the start,” said study authorContinue Reading